Neurologic dengue manifestations associated with intrathecal specific immune response

Neurology

Volumn 73, Issue 17, 2009, Pages 1413-1417

  Puccioni Sohler, M ^a,b,d   Soares, C N ^a,e   Papaiz Alvarenga, R ^b   Castro, M J C ^a,c   Faria, L C ^a   Peralta, J M ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Servico de Neurologia   (Brazil)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^d CSF Neurolife Laboratory   (Brazil)

^e FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; ENCEPHALITIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; MALE; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBARACHNOID SPACE;

ADULT; AGED; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; ENCEPHALITIS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MYELITIS; OPTIC NEURITIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70350548216     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181bd8258     Document Type: Article

References (23)

1. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003;27:1-13.
2. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006;354:119-130.
3. Nogueira RMR, de Araújo JMG, Schatzmayr HG. Dengue viruses in Brazil, 1986-2006. Rev Panam Salud Pu-blica 2007;22:358-363.
4. Maciel IJ, Júnior JBS, Martelli CM. Epidemiologia e desa-fios no controle do dengue. Rev Patol Trop 2008;37:111-130.
5. Lum LC, Lam SK, Choy YS, George R, Harun F. Dengue encephalitis: a true entity? Am Trop Med Hyg 1996;54: 256-259.
6. Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000;355:1053-1059.
7. Misra UK, Kalita J, Syam UK, Dhole TN. Neurological manifestations of dengue virus infection. J Neurol Sci 2006;244:117-122.
8. Miagostovich MP, Ramos RG, Nicol AF, et al. Retrospective study on dengue fatal cases. Clin Neuropathol 1997; 16:204-208.
9. Pancharoen C, Thisyakorn U. Neurological manifestations in dengue patients. Southeast Asian J Trop Med Public Health 2001;32:341-345.
10. Thisyakorn U, Thisyakorn C, Limpitikul W, Nisalak A. Dengue infection with central nervous system manifestations. Southeast Asian J Trop Med Public Health 1999;30: 504-506.
11. Yamamoto Y, Takasaki T, Yamada K, et al. Acute disseminated encephalomyelitis following dengue fever. J Infect Chemother 2002;8:175-177.
12. Soares CN, Faria LC, Peralta JM, Freitas MRG, Puccioni-Sohler M. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 2006; 249:19-24.
13. Miranda de Sousa A, Puccioni-Sohler M, Dias Borges A, Fernandes Adorno L, Papais Alvarenga M, Papais Al-varenga RM. Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child. J Infect Che-mother 2006;12:396-398.
14. World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd ed. Geneva, Switzerland: WHO; 1997.
15. Puccioni-Sohler M. Diagnóstico de Neuroinfecção. Rio de Janeiro: Rubio; 2008.
16. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991;37:1153-1160.
17. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987;163:319-328.
18. Victor M, Ropper AH. Principles of Neurology, 7th ed. New York: McGraw Hill; 2001.
19. Fishmann RA. Cerebrospinal Fluid in Diseases of the Nervous System, 2nd ed. Philadelphia: WB Saunders Company; 1992.
20. Sa-Ngasang A, Anantapreecha S, A-Nuegoonpipat A, et al. Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked im-munosorbent assay. Epidemiol Infect 2006;134:820-825.
21. Jacobi C, Lange P, Reiber H. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing pa-nencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response. J Neuroimmunol 2007;187:139-146.
22. Sindic CJM, Van Antwerpen MP, Goffette S. The intra-thecal humoral immune response: laboratory analysis and clinical relevance. Clin Chem Lab Med 2001;39:333-340.
23. Chimelli L, Hahn MD, Netto MB, Ramos RG, Dias M, Gray F. Dengue: neuropathological findings in 5 fatal cases from Brazil. Clin Neuropathol 1990;9:157-162.